Law 6

The DHCG Leadership Team

The leadership team at DHC Group has over 50 years of industry experience working with innovative companies, brands, and teams as well as with a wide range of pharmaceutical, biotech, and medical device companies across the globe.

Expanding on the legacy of the 501(c)(3) nonprofit organization Digital Health Coalition, the DHC Group funds and conducts research, hosts and produces industry events, while offering media and outreach opportunities for its members. The DHC Group partners with numerous industry outlets, including the Digital Health Coalition, to drive industry thought leadership forward and and make research-supported content available to a broader audience of pharmaceutical, media, publishing, technology, and advertising firms interested in the future of digital health, marketing, and customer experience.

At the DHC Group, we pride ourselves on being at the nexus of pharmaceutical innovation and digital health. Our strategic research initiatives keep our vast network informed about the latest trends in digital pharmaceutical marketing. By partnering with global market-leading firms, we offer our members top-tier advisory services, combining deep industry knowledge with both strategic and practical advice. Our events, including exclusive DHC Summits, serve as platforms for thought leadership, direct engagement with pharmaceutical marketers, and intimate networking opportunities with industry pioneers. Furthermore, our commitment to shaping the future of digital health is evident in our proactive approach to addressing upcoming challenges and our emphasis on collaborative projects that drive industry advancement. As members of the DHC Group, individuals and organizations are positioned at the forefront of industry advancements, ensuring they’re always prepared for the evolving digital health landscape

THE DHCG TEAM. FOCUSED ON RESULTS.

MARK BARD

CO-FOUNDER, Managing Partner

JOE FARRIS

CO-FOUNDER, Managing Partner

CHRISTINE FRANKLIN

EXECUTIVE DIRECTOR

“Bringing together industry thought leaders through research, data, events, and membership opportunities.”
MARK BARD • CO-FOUNDER

PUBLICATIONS AND NEWS

DHC Group and Intouch Group Publish Whitepaper on Effectively Engaging Audiences in the COVID-19 Era

The DHC Group and Intouch Group announced that, together, they have published a new whitepaper titled The Now & The Next in Pharma Marketing. The whitepaper delves deep into practical solutions for the challenges pharmaceutical commercial organizations continue to face as a result of the COVID-19 pandemic. Areas covered include evolving the pharmaceutical marketing commercial strategy, real-world solutions and specific tactics to implement now, even as COVID-19 vaccines are beginning to be administered.

PRIVACY FIRST MARKETING: AN INDUSTRY POV

The shift away from (browser-based) cookies by Apple, Firefox, and Google has ushered in a new era of targeting and audience metrics for brands, marketers, and agencies. This shift will have an acute impact on the approach pharma companies will have to take to successfully promote their products online.

The DHC Group and its members will be affected by these privacy-first changes – so we turned to our membership to gain a better understanding of some of the challenges and opportunities facing pharma brand marketers. The DHC Group interviewed more than 20 leading digital marketing experts from ad tech, data firms, agencies, publishers, and pharmaceutical organizations and asked them how they plan to adapt to the “privacy-first” era – and what’s ahead for audience targeting, tracking, and metrics.

OUR MEMBERS